PUNE, India, January 23, 2023 (GLOBE NEWSWIRE) — The global contraceptive market The size was $22.49 billion in 2019. It is forecast to increase by US$30.15 billion in 2027 at a CAGR of 5.5% over the forecast period. Fortune Business Insights™ published this information in the latest study, Contraceptives Market Forecast, 2023-2027.

Industry Developments:

• The US Food and Drug Administration (FDA) has approved a non-hormonal vaginal gel called Phexxi. It was developed by the University of Illinois Chicago. It is a combination of potassium bitartrate, citric acid and lactic acid.
• According to a study conducted by medRvix, female sex hormones can prevent transmission of COVID-19. Some birth control pills, such as combination pills and estrogen-only pills, can help reduce the severity and vulnerability of COVID-19. However, due to the risk of side effects, the researchers advise against self-medication.

Request a sample copy of the research report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptives-market-100064

Report scope and segmentation

The central theses:

• Rising awareness of several new birth control pills will continue to fuel product demand.
• An increasing number of clinical trials on contraceptive methods for better efficacy strongly suggest a positive growth path over the analysis period.
• The contraceptive market segment is expected to grow lucratively during the forecast period.
• The market size in North America was US$9.71 billion in 2019.

For more information on the analysis of this report, see: https://www.fortunebusinessinsights.com/industry-reports/contraceptives-market-100064

Driver & Restraints-

government growth…